Polycystic Ovarian Syndrome Treatment Market to Reach USD 3.5 Billion by 2030, Driven by Drug Therapies and Rising Awareness in Asia-Pacific

Mordor Intelligence has published a new report on the Polycystic Ovarian Syndrome Treatment Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The global polycystic ovarian syndrome (PCOS) Treatment Market to expand at a compound annual growth rate (CAGR) of 5.2% between 2025 and 2030, with North America remaining the largest market and Asia‐Pacific showing the fastest growth.

Polycystic Ovarian Syndrome (PCOS) affects 6-12% of women of reproductive age, making it the leading endocrine disorder among that group. PCOS treatment market covers a wide array of therapies - from oral contraceptives and insulin-sensitising agents to laparoscopic surgery - and is crucial for managing both reproductive and metabolic symptoms.

The market witnessed some disruption during the COVID-19 pandemic, with elective procedures delayed and supply chains affected, though demand for medication remained steady. Looking ahead, increasing awareness among patients and health providers, as well as ongoing clinical trials, are expected to fuel the market's steady growth.

Report Overview: https://www.mordorintelligence.com/industry-reports/polycystic-ovarian-syndrome-treatment-market?utm_source=openpr

Key Trends

Rise in R&D and Symptom-focused Approaches
Major pharmaceutical players are focusing on drug classes that address key PCOS symptoms. For example, insulin-sensitising agents remain essential due to their role in treating underlying metabolic dysfunctions.

Asia-Pacific to Drive Growth
Asia‐Pacific is the region expected to grow fastest, thanks to higher prevalence rates in countries like India and China, along with improved access to healthcare and increasing PCOS awareness.

North America Retains Leading Share
Strong healthcare infrastructure and early diagnosis protocols have kept North America in the leading market position, with estimates indicating a market of USD 2.2 billion in 2023 and anticipating USD 3.5 billion by 2032.

New Drug Trials and Biopharma Investing
AbbVie is currently running a phase II trial of Elagolix for PCOS symptom relief, reflecting a broader trend of pipeline expansion and targeted therapies.

Market Segmentation

The PCOS treatment market is divided across two main axes:

By Treatment Type

Drug Classes

Oral contraceptives

Insulin-sensitising agents (e.g., metformin)

Antidepressants

Anti-obesity medications

Other drug categories

Surgical Interventions

Ovarian wedge resection

Laparoscopic ovarian drilling

Miscellaneous surgical procedures

By Geography

North America (United States, Canada, Mexico)

Europe (UK, Germany, France, Italy, Spain, others)

Asia-Pacific (China, Japan, India, Australia, South Korea, rest APAC)

Middle East & Africa (GCC countries, South Africa, others)

South America (Brazil, Argentina, others)

Explore Our Full Library of Healthcare Industry Research Reports

https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

Key Players

Mordor Intelligence identifies the pharmaceutical landscape as consisting of established global firms and specialist biotech entities. The leading companies include:

Pfizer

Teva Pharmaceutical

Novartis

Takeda

Bayer AG

Explore more about major players in the market: https://www.mordorintelligence.com/industry-reports/polycystic-ovarian-syndrome-treatment-market/companies?utm_source=openpr

Conclusion

With a forecasted CAGR of 5.2%, the global PCOS treatment market is set to expand steadily, driven by ongoing drug development, rising patient awareness, and greater healthcare access, particularly in emerging regions. North America is expected to retain the leading share, but Asia‐Pacific's rapid growth signals a shift toward broader treatment uptake. As major companies deepen their commitment-through trials, acquisitions, and alliances-the impact on therapeutic options is likely to be substantial. Providers, payers, and policymakers should watch closely for new approvals and clinical advances that could enhance care quality and improve health outcomes for millions of women worldwide.

Industry Related Reports

Gynaecology Drugs Market: The Gynaecology Drugs Market report segments the industry into By Therapeutics (Hormonal Therapy, Non-hormonal Therapy), By Indication (Gynaecology Cancers, Menopausal Disorder, Contraception, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).

Get More insights: https://www.mordorintelligence.com/industry-reports/gynecology-drugs-market?utm_source=openpr

Hirsutism Market: The Report Covers Global Hirsutism Treatment Market Share & Trends and It is Segmented by Therapy (Procedures and Medications) and End User (Hospitals, Clinics and Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Provides the Value (in USD Million) for the Above Segments.

Get More insights: https://www.mordorintelligence.com/industry-reports/hirsutism-market?utm_source=openpr

Fertility Treatment Market: The Fertility Treatment Market Report is Segmented by Gender (Female Infertility and Male Infertility), Treatment (In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Infertility Drugs, and Surgery), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers Market Size and Forecasts in Value (USD) for the Above Segments.

Get More insights: https://www.mordorintelligence.com/industry-reports/global-fertility-treatment-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.